Determinants of re‐compensation in patients with hepatitis B virus‐related decompensated cirrhosis starting antiviral therapy
Author:
Affiliation:
1. Department of Internal Medicine Korea University College of Medicine Seoul Korea
2. Department of Biostatistics Korea University College of Medicine Seoul Korea
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16658
Reference27 articles.
1. Epidemiology of Hepatitis B Virus Infection in the United States
2. Korea Health Statistics 2018: Korea National Health and Nutrition Examination Survey (KNHANES Ⅶ‐3).Ministry of Health and Welfare.2019.
3. Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis
4. Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis
5. Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria;Hepatology Communications;2023-12-22
2. New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey’s discriminant function <32;Hepatology International;2023-10-13
3. Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease;Nature Reviews Gastroenterology & Hepatology;2023-10-05
4. Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding;Hepatology International;2023-09-29
5. Recompensation in treatment-naive HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding;HEPATOL INT;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3